Man Group PLC Charles River Laboratories International, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Man Group PLC holds 17,934 shares of CRL stock, worth $3.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,934

Previous 12,333 45.41%

Holding current value

$3.47 Million

Previous $2.55 Million 38.67%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $1.05 Million - $1.37 Million	5,601 Added 45.41%	17,934 $3.53 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $2.55 Million - $3.31 Million	12,333 New	12,333 $2.55 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $5.39 Million - $7.98 Million	26,397 Added 99.19%	53,010 $11.3 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $4.95 Million - $7.02 Million	19,383 Added 268.09%	26,613 $7.56 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $2.4 Million - $3.06 Million	-6,818 Reduced 48.53%	7,230 $2.72 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $11 Million - $13.5 Million	-29,531 Reduced 67.76%	14,048 $5.8 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $5.91 Million - $7.47 Million	20,090 Added 85.53%	43,579 $16.1 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $8.29 Million - $9.94 Million	-33,202 Reduced 58.57%	23,489 $6.81 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $6.72 Million - $7.64 Million	30,249 Added 114.4%	56,691 $14.2 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $3.41 Million - $4.4 Million	19,431 Added 277.15%	26,442 $5.99 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $4.06 Million - $6.49 Million	-34,186 Reduced 82.98%	7,011 $1.22 Million
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $4.81 Million - $8.67 Million	-48,594 Reduced 54.12%	41,197 $5.2 Million
Q4 2019 Feb 18, 2020	BUY	$126.05 - $152.76 $8.24 Million - $9.99 Million	65,385 Added 267.91%	89,791 $13.7 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $3.2 Million - $3.67 Million	-25,561 Reduced 51.16%	24,406 $3.23 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $5.91 Million - $7.11 Million	-47,889 Reduced 48.94%	49,967 $7.09 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $4.68 Million - $6.55 Million	44,645 Added 83.9%	97,856 $14.2 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $3.71 Million - $4.84 Million	-35,259 Reduced 39.85%	53,211 $6.02 Million
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $1.9 Million - $2.28 Million	16,952 Added 23.7%	88,470 $11.9 Million
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $4.28 Million - $4.9 Million	41,776 Added 140.46%	71,518 $8.03 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $2.92 Million - $3.43 Million	29,742 New	29,742 $3.17 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.84B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account